{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:54:59Z","timestamp":1791165299404,"version":"4.1.0"},"reference-count":62,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,8,3]],"date-time":"2009-08-03T00:00:00Z","timestamp":1249257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pain Practice"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Neuropathic pain is a considerable burden that affects activities of daily living. The management of neuropathic pain can be challenging because of multiple etiologies and complex manifestations. Ziconotide is a nonopioid intrathecal (IT) analgesic option for patients with neuropathic pain refractory to conventional treatments. The objective of this article is to review the published literature on ziconotide for the treatment of neuropathic pain. Relevant publications were identified through searches of all years of 6 databases, which included PubMed, EMBASE, and CINAHL. Search terms used were<jats:italic>ziconotide<\/jats:italic>,<jats:italic>SNX\u2010111<\/jats:italic>,<jats:italic>MVIIA<\/jats:italic>,<jats:italic>Prialt<\/jats:italic>, and<jats:italic>neuropathic pain<\/jats:italic>. Publications were included if ziconotide was intrathecally administered (either alone or in combination with other IT agents) to treat neuropathic pain of any etiology and if pain assessment was an outcome measure. Data extracted included study design, IT drug doses, pain outcome measures, and adverse events (AEs). Twenty\u2010eight articles met the inclusion criteria: 5 were preclinical studies and 23 were clinical studies. In the preclinical studies, ziconotide demonstrated antiallodynic effects on neuropathic pain. Data from double\u2010blind, placebo\u2010controlled (DBPC) trials indicated that patients with neuropathic pain reported a mean percent improvement in pain score with ziconotide monotherapy that ranged from 15.7% to 31.6%. A low starting dose and slow titration of ziconotide resulted in an improved safety profile in the aforementioned trials. Common AEs associated with ziconotide include nausea and\/or vomiting, dizziness, confusion, urinary retention, and somnolence. Evidence from DBPC trials, open\u2010label studies, case series, and case studies suggests that ziconotide, as either monotherapy or in combination with other IT drugs, is a potential therapeutic option for patients with refractory neuropathic pain. Additional studies are needed to establish the long\u2010term efficacy and safety of ziconotide for neuropathic pain.<\/jats:p>","DOI":"10.1111\/j.1533-2500.2009.00303.x","type":"journal-article","created":{"date-parts":[[2009,8,4]],"date-time":"2009-08-04T02:35:26Z","timestamp":1249353326000},"page":"327-337","source":"Crossref","is-referenced-by-count":86,"title":["Intrathecal Ziconotide for Neuropathic Pain: A Review"],"prefix":"10.1111","volume":"9","author":[{"given":"Richard L.","family":"Rauck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen W.","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Kapural","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"North","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,9,2]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2008.03.002"},{"key":"e_1_2_7_3_2","first-page":"121","volume-title":"Expert Guide to Pain Management","author":"McCarberg B","year":"2005"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1602\/neurorx.2.4.650"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-007-0192-6"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(99)00154-2"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1533-2500.2006.00052.x"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(03)00101-7"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(88)90148-0"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(90)90023-7"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(91)90019-T"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(98)00256-5"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(97)00168-1"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021420"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002508-200205000-00002"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2000.tb00134.x"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.4071055"},{"key":"e_1_2_7_18_2","unstructured":"PRIALT\u00ae[Package Insert]. South San Francisco CA:Elan Pharmaceuticals Inc.;2008."},{"key":"e_1_2_7_19_2","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0022-3565(25)21283-6","article-title":"Selective N\u2010type neuronal voltage\u2010sensitive calcium channel blocker, SNX\u2010111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain","volume":"279","author":"Bowersox SS","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_7_20_2","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0022-3565(25)38848-8","article-title":"Role of voltage\u2010dependent calcium channel subtypes in experimental tactile allodynia","volume":"269","author":"Chaplan SR","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(02)02247-1"},{"key":"e_1_2_7_22_2","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0022-3565(25)10579-X","article-title":"Synthetic omega\u2010conopeptides applied to the site of nerve injury suppress neuropathic pains in rats","volume":"274","author":"Xiao W\u2010H","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(98)00306-0"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2005.10.003"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.1.63"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1403.2006.00055.x"},{"key":"e_1_2_7_27_2","first-page":"195","article-title":"Effectiveness of intrathecal ziconotide in multiple pain etiologies: a meta\u2010analysis of three controlled trials [abstract 159","volume":"6","author":"Collins R","year":"2005","journal-title":"Pain Med"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2007.00355.x"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1213\/ane.0b013e3181606fad"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2007.00356.x"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1403.2007.00141.x"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1177\/0091270003253349"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4637.2002.202420.x"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1533-2500.2009.00289.x"},{"key":"e_1_2_7_35_2","first-page":"61","article-title":"Intrathecal ziconotide and baclofen provide pain relief in seven patients with neuropathic pain and spasticity: case reports","volume":"45","author":"Saulino M","year":"2009","journal-title":"Eur J Phys Rehabil Med"},{"key":"e_1_2_7_36_2","first-page":"147","article-title":"Treatment challenges and complications with ziconotide monotherapy in established pump patients","volume":"9","author":"Thompson JC","year":"2006","journal-title":"Pain Physician"},{"key":"e_1_2_7_37_2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00002508-199709000-00012","article-title":"Use of intrathecal SNX\u2010111, a novel, N\u2010type, voltage\u2010sensitive, calcium channel blocker, in the management of intractable brachial plexus avulsion pain","volume":"13","author":"Brose WG","year":"1997","journal-title":"Clin J Pain"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2004.02.193"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(99)00254-7"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1403.2001.00121.x"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1403.2006.00044.x"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.26.3.395"},{"key":"e_1_2_7_43_2","first-page":"170","article-title":"Intrathecal ziconotide for chronic, severe pain: a case study [abstract 111","volume":"6","author":"Fisher R","year":"2005","journal-title":"Pain Med"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.sc.3102027"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2006.08.002"},{"key":"e_1_2_7_46_2","first-page":"19","article-title":"Ziconotide: a non\u2010opioid alternative for chronic neuropathic pain, a case report","volume":"25","author":"Madaris L","year":"2008","journal-title":"SCI Nursing"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.2174\/0929867043363884"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2008.02.016"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1403.2007.00128.x"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(92)90041-9"},{"key":"e_1_2_7_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(88)90209-6"},{"key":"e_1_2_7_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(90)91074-S"},{"key":"e_1_2_7_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(04)90171-3"},{"key":"e_1_2_7_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2005.08.013"},{"key":"e_1_2_7_55_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.60.11.1524"},{"key":"e_1_2_7_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(99)00241-9"},{"key":"e_1_2_7_57_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704439"},{"key":"e_1_2_7_58_2","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0022-3565(24)37037-5","article-title":"d\u2010Methadone is antinociceptive in the rat formalin test","volume":"283","author":"Shimoyama N","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_7_59_2","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.36076\/ppj.2008\/11\/S89","article-title":"Intrathecal drug delivery","volume":"11","author":"Smith HS","year":"2008","journal-title":"Pain Physician"},{"key":"e_1_2_7_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-3019(01)00353-6"},{"key":"e_1_2_7_61_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200608000-00036"},{"key":"e_1_2_7_62_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1403.2008.00147.x"},{"key":"e_1_2_7_63_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4637.2002.02055.x"}],"container-title":["Pain Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1533-2500.2009.00303.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1533-2500.2009.00303.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T16:25:01Z","timestamp":1739291101000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1533-2500.2009.00303.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1111\/j.1533-2500.2009.00303.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1533-2500.2009.00303.x","archive":["Portico"],"relation":{},"ISSN":["1530-7085","1533-2500"],"issn-type":[{"value":"1530-7085","type":"print"},{"value":"1533-2500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}